-
First COVID-19 variant vaccine AZD2816 Phase II/III trial participants vaccinated
firstwordpharma
June 28, 2021
The first participants in a Phase II/III trial for the new COVID-19 variant vaccine AZD2816 were vaccinated today to assess its safety and immunogenicity in both previously vaccinated and unvaccinated adults.
-
U.S. Sends 3 Million J&J COVID-19 Vaccine Doses to Brazil
drugs
June 25, 2021
The United States is sending 3 million doses of the Johnson & Johnson' COVID-19 vaccine to Brazil, as that country struggles with a surge in cases and its death toll climbs above 500,000.
-
Venezuela receives first shipment of Cuban coronavirus vaccine
firstwordpharma
June 25, 2021
Venezuela’s vice president Delcy Rodriguez said the country received its first shipment of doses of Cuba's Abdala COVID-19 vaccine on Thursday, as reported in This is Money.
-
Rash, Itch After COVID Vaccine Rare & Quickly Resolves
drugs
June 24, 2021
Rashes, itchiness and other skin problems can develop after people receive COVID-19 vaccines, but such problems are rare and go away quickly, new research shows.
-
Study Suggests COVID Vaccine Booster Shots Will Be Needed
drugs
June 24, 2021
One dose of a two-dose mRNA COVID-19 vaccine is enough to protect previously infected people, but it's likely they and everyone with two doses will still require booster shots at a later date, a new study suggests.
-
Japan mulls approving AstraZeneca COVID vaccine for people 18 and over
firstwordpharma
June 24, 2021
According to sources, Japan is considering approving the use of AstraZeneca's COVID-19 vaccine for people aged 18 or over, as reported Kyodo News+ on Wednesday.
-
SAHPRA and the Sinopharm Vaccine
firstwordpharma
June 24, 2021
SAHPRA has received documentation for the Sinopharm vaccine developed by the China National Pharmaceutical Group in China.
-
Siemens and BioNTech expand their collaboration for global vaccine production
firstwordpharma
June 24, 2021
Siemens supplies the latest automation and digitalization technology for the production of Covid-19 vaccines
-
COVID-19 Vaccine Coverage in U.S. Highest Among ≥65-Year-Olds
drugs
June 23, 2021
COVID-19 vaccine coverage is 80.0 percent among those aged 65 years and older, while 34.0 percent of those aged 18 to 39 years report having received a COVID-19 vaccine, according to two studies published in the June 21 early-release issue
-
Astrazeneca COVID-19 vaccine effective against variants found in India
firstwordpharma
June 23, 2021
AstraZeneca, citing a study, said its COVID-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, as reported by U.S. News & World Report.